Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:42:54.206Z.
Calculation as of: 2026-10-06T19:42:54.206Z.
Quote observation: 2026-10-06T19:31:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9eb175beb73ea6d5bc2b5d4e57ff3726ad64c6dbf03440990cee379981bf6545
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Psyence Biomedical Ltd.
Market Cap
$97282.00
Operating Cash Flow Yield
N/A
Market Cap
$28295.00
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| Psyence Biomedical Ltd. (PBM) | $97282.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109693.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $71190.00 | N/A |
| Akanda Corp. (AKAN)vs › | $60201.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $30713.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $28295.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6115.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $355726.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $401484.00 | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
